America's GMO firms face China hurdle
Chinese consumer wariness over GMO safety has risen of late, and at the same time, Chinese regulatory approvals have ground to a near halt
Kansas City, Missouri
WITH US approval for Dow AgroSciences' package of chemicals and new genetically engineered crops now in hand, the Dow Chemical Co unit faces a major obstacle to a US$1 billion market opportunity: Chinese import barriers.
The Asian nation has become a major buyer of US corn and soyabeans in recent years, but has also shown mounting reluctance to accept some genetically modified crops grown by US farmers. China for the last year has been rejecting US corn shipments containing traces of a type of GMO corn developed by Syngenta AG.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Energy & Commodities
India's Vedanta misses Q4 profit estimates on lower prices
BHP targets Anglo American in bid valuing miner at US$39 billion
China's Sinopec charts global expansion with refinery in rival India's backyard
Gold trades in tight range as market focuses on US economic data
Oil settles lower as US business activity cools, concerns over Middle East ease
Orsted says Taiwan wind project to power TSMC on track for 2025 finish